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Background
Extracorporeal membrane oxygenation (ECMO) is used
for severe lung and/or heart failure in intensive care
units (ICU). The Prince Charles Hospital (TPCH) has
one of the largest ECMO units in Australia. Its use
rapidly increased during the H1N1 (“swine flu”) pan-
demic and an increase in pedal complications resulted.
The relationship between ECMO and pedal complica-
tions has been described, particularly in children, though
no strong data exists. This paper presents a case series
of foot complications in patients having received ECMO
treatment.
Methods
We present nine cases of severe foot complications
resulting from patients receiving ECMO treatment at
TPCH in 2009–2012.
Results
Case ages ranged from 16 - 58 years and three were male.
Six cases had an unremarkable medical history prior to
H1N1 or H1N2 infection, one had Cardiomyopathy, one
had received a lung transplant, and one had multi-organ
failure post-sepsis. Common medications prescribed
included vasopressors, antibiotics, and sedatives. All cases
showed signs of markedly impaired peripheral perfusion
whilst on ECMO and seven developed increasing areas of
foot necrosis. Outcomes include two bilateral below knee
amputations, two multiple digital amputations, one Reflex
Sympathetic Dystrophy Syndrome, three pressure injuries,
and three deaths.
Conclusion
Necrosis of the feet appears to occur more readily in
younger people requiring ECMO treatment than others in
ICU. The authors are conducting further studies to inves-
tigate associations between particular infections, medical
history, medications, or machine techniques and severe
foot complications. Some of these early results will also be
presented at this conference.
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